The European IVF market is expected to reach $4,447 million in 2022 growing at a CAGR of 5.4%, from $3,054 million in 2015. Delayed pregnancy in women is a major factor that drives the European market, as the chances of conceiving lowers with age and the success rate of getting pregnant via in vitro fertilization reduces with increase in age. Other factors that accelerate the market growth are rise in infertility rate due to increase in stress levels, change in lifestyle, and fertility-related diseases Research Beam Model: Research Beam Product ID: 1070271 5370 USD New
Europe In Vitro Fertilization (IVF) Market by Cycle Type (Fresh Cycle, Thawed IVF Cycle, and Donor Egg IVF Cycle) and End User (Fertility Clinics, Hospitals, Surgical Centers, and Clinical Research Institutes) - Opportunity Analysis and Industry Forecast, 2014-2022

Toll Free : +1 (800)910-6452

 
 
PURCHASE OPTIONS
 

Europe In Vitro Fertilization (IVF) Market by Cycle Type (Fresh Cycle, Thawed IVF Cycle, and Donor Egg IVF Cycle) and End User (Fertility Clinics, Hospitals, Surgical Centers, and Clinical Research Institutes) - Opportunity Analysis and Industry Forecast, 2014-2022

 
  • Category : Healthcare
  • Published On : December  2016
  • Pages : 148
 
 

The European IVF market is expected to reach $4,447 million in 2022 growing at a CAGR of 5.4%, from $3,054 million in 2015. Delayed pregnancy in women is a major factor that drives the European market, as the chances of conceiving lowers with age and the success rate of getting pregnant via in vitro fertilization reduces with increase in age. Other factors that accelerate the market growth are rise in infertility rate due to increase in stress levels, change in lifestyle, and fertility-related diseases.

In Europe, government regulations are favorable towards IVF treatments. The presence of regulatory and reimbursement policies such as three-parent IVF treatments and Human Fertilization and Embryo Authority (HFEA) guidelines contribute to high market growth. IVF treatments have been criticized across various regions on ethical grounds. For instance, few incidences have been reported in the past for mixing-up of embryos. Hence, the HFEA, which closely regulates the IVF treatments and research in UK, adopted the double-witness system to minimize chances of embryo mix-up in clinics. However, lack of reimbursements in Russia is expected to limit the growth of the Russian IVF market during the forecast period.

KEY BENEFITS FOR STAKEHOLDERS:

  • This report provides an in-depth analysis of the European IVF market across eight major countries along with cross-sectional analysis of the total number of IVF cycles performed and the total revenue generated during the forecast period.
  • It includes the strategies adopted by various IVF clinics and hospitals across major countries to capitalize on the latent opportunities in the market.
  • The projections are made by analyzing the current market trends and highlighting the market potential, in terms of value and volume, from 2014 to 2022.
  • Extensive analysis of the market is conducted by monitoring the top contenders.

KEY MARKET SEGMENTS:

By End User (Value and Volume)

  • Fertility Clinics
  • Hospitals
  • Surgical Centers
  • Clinical Research Institutes

By Cycle Type (Value and Volume)

  • Fresh Cycle (Non-Donor)
  • Thawed IVF Cycle (Non-Donor)
  • Donor Egg IVF Cycle

By Cycle Type Country Level Analysis (Value and Volume)

  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Denmark
  • Russia
  • Rest of Europe

Key Companies

  • Thermo Fisher Scientific, Inc.
  • DRK Kliniken Berlin
  • Sun Pharmaceutical Industries Ltd.
  • Cadila Healthcare Ltd.
  • LG Life Sciences
  • EMD Serono Inc.

Chapter: 1 INTRODUCTION

1.1 Report Description
1.2 Key Benefits
1.3 Coverage and Limitations
1.4 Research Methodology

1.4.1 Secondary research
1.4.2 Primary research
1.4.3 Analyst tools and models

Chapter: 2 EXECUTIVE SUMMARY

Chapter: 3 EUROPE IVF MARKET ANALYSIS

3.1 Market Definition and Scope
3.2 Overview
3.3 Drivers

3.3.1 Delayed pregnancies in women
3.3.2 Supportive regulations

3.4 Restraints

3.4.1 Inadequate reimbursement policies
3.4.2 Ethical considerations

3.5 Europe IVF Market by Country
3.6 Europe IVF Market by Cycle Type
3.7 Europe IVF Market by End Users
3.8 Company Profile

3.8.1 Thermo Fisher Scientific, Inc.
3.8.2 DRK Kliniken Berlin
3.8.3 Sun Pharmaceutical Industries Ltd.
3.8.4 Cadila Healthcare Ltd. (Zydus Cadila Group)
3.8.5 LG Life Sciences

Chapter: 4 GERMANY EMBRYO TRANSFER MARKET

4.1 Overview
4.2 Germany IVF Market by Cycle Type

4.2.1 Fresh IVF cycles (non-donor)
4.2.2 Thawed IVF cycles (non-donor)

4.3 Number of Infertility Clinics, 2015
4.4 Germany IVF Market by End Users

4.4.1 Fertility clinics
4.4.2 Hospitals
4.4.3 Surgical centers
4.4.4 Clinical research institutes

4.5 Drivers

4.5.1 Subsidizing IVF treatments
4.5.2 Delayed marriages and parenthood decisions

4.6 Restraints

4.6.1 Stringent government regulations
4.6.2 Lack of availability in treatment cycles for IVF

4.7 Regulatory Issues, Legislations, and Authorities
4.8 Insurance Reimbursement Scenario
4.9 Hospitals/Clinics Profile

4.9.1 Heidelberg University Hospital
4.9.2 Klinikum Stuttgart
4.9.3 DRK Kliniken Berlin
4.9.4 University Medical Center Freiburg

Chapter: 5 FRANCE EMBRYO TRANSFER MARKET

5.1 Overview
5.2 France IVF Market by Cycle Type

5.2.1 Fresh IVF cycles (non-donor)
5.2.2 Thawed IVF cycles (non-donor)
5.2.3 Donor egg IVF cycles

5.3 Number of Infertility Clinics, 2015
5.4 France IVF Market by End Users

5.4.1 Fertility clinics
5.4.2 Hospitals
5.4.3 Surgical centers
5.4.4 Clinical research institutes

5.5 Drivers

5.5.1 Same gender adoption of IVF babies
5.5.2 Lower rates of fertility

5.6 Restraints

5.6.1 Stringent government regulations

5.7 Regulatory Issues, Legislations, and Authorities
5.8 Insurance Reimbursement Scenario
5.9 Hospitals/Clinics Profile

5.9.1 Clinique de la Muette
5.9.2 Hopital des metallurgists, hopital cochin

Chapter: 6 UK EMBRYO TRANSFER MARKET

6.1 Overview
6.2 UK IVF Market by Cycle Type

6.2.1 Fresh IVF cycles (non-donor)
6.2.2 Thawed IVF cycles (non-donor)
6.2.3 Donor egg IVF cycles

6.3 Number of Infertility Clinics, 2015
6.4 UK IVF Market by End Users

6.4.1 Fertility clinics
6.4.2 Hospitals
6.4.3 Surgical centers
6.4.4 Clinical research institutes

6.5 Drivers

6.5.1 Commercialization of three-parent IVF procedures
6.5.2 Supportive regulations

6.6 Restraints

6.6.1 Ethical considerations

6.7 Regulatory Issues, Legislations, and Authorities
6.8 Insurance Reimbursement Scenario
6.9 Hospitals/Clinics Profile

6.9.1 Lister Fertility Clinic
6.9.2 The Bridge Center
6.9.3 Chelsea and Westminster Hospital (Assisted Conception Unit)

Chapter: 7 ITALY EMBRYO TRANSFER MARKET

7.1 Overview
7.2 Italy IVF Market by Cycle Type

7.2.1 Fresh IVF cycles (non-donor)
7.2.2 Thawed IVF cycles (non-donor)

7.3 Italy IVF Market by End Users

7.3.1 Fertility clinics
7.3.2 Hospitals
7.3.3 Surgical centers
7.3.4 Clinical research institutes

7.4 Drivers

7.4.1 Growing medical tourism

7.5 Restraints

7.5.1 Ban on surrogacy

7.6 Regulatory issues, legislations, and authorities
7.7 Insurance Reimbursement Scenario
7.8 Hospitals/Clinics Profile

7.8.1 ARC-STER srl
7.8.2 RAPRUI
7.8.3 Centre for Reproductive Medicine-Napoli

Chapter: 8 SPAIN EMBRYO TRANSFER MARKET

8.1 Overview
8.2 Spain IVF Market by Cycle Type

8.2.1 Fresh IVF cycles (non-donor)
8.2.2 Thawed IVF cycles (non-donor)
8.2.3 Donor egg IVF cycles

8.3 Spain IVF Market by End Users

8.3.1 Fertility clinics
8.3.2 Hospitals
8.3.3 Surgical centers
8.3.4 Clinical research institutes

8.4 Drivers

8.4.1 Increase in the number of foreign patients

8.5 Restraints

8.5.1 Low awareness pertaining to IVF technology

8.6 Regulatory Issues, Legislations, and Authorities
8.7 Insurance Reimbursement Scenario
8.8 Hospitals/Clinics Profiles

8.8.1 IVF spain
8.8.2 Clnica EUGIN Barcelona

Chapter: 9 DENMARK EMBRYO TRANSFER MARKET

9.1 Overview
9.2 Denmark IVF Market by Cycle Type

9.2.1 Fresh IVF cycles (non-donor)
9.2.2 Thawed IVF cycles (non-donor)
9.2.3 Donor egg IVF cycles

9.3 Denmark IVF Market by End Users

9.3.1 Fertility clinics
9.3.2 Hospitals
9.3.3 Surgical centers
9.3.4 Clinical research institutes

9.4 Drivers

9.4.1 Increase in disposable income
9.4.2 Advances in IVF technology

9.5 Restraints

9.5.1 Inadequate reimbursement policies

9.6 Regulatory Issues, Legislations, and Authorities
9.7 Insurance Reimbursement Scenario
9.8 Hospitals/Clinics Profiles

9.8.1 Copenhagen Fertility Center
9.8.2 Storkklinik v/Nina Stork
9.8.3 Vitanova
9.8.4 Trianglen fertility clinic
9.8.5 NordicaDenmark, Copenhagen

Chapter: 10 RUSSIA EMBRYO TRANSFER MARKET

10.1 Overview
10.2 Russia IVF Market by Cycle Type

10.2.1 Fresh IVF cycles (non-donor)
10.2.2 Thawed IVF cycles (non-donor)
10.2.3 Donor egg IVF cycles

10.3 Russia IVF Market by End User

10.3.1 Fertility clinics
10.3.2 Hospitals
10.3.3 Surgical centers
10.3.4 Clinical research institutes

10.4 Drivers

10.4.1 Rising popularity of fertility tourism

10.5 Restraints

10.5.1 Inadequate reimbursement policies

10.6 Regulatory Issues, Legislations, and Authorities
10.7 Insurance Reimbursement Scenario
10.8 Hospital/Clinics Profiles

10.8.1 AVA-Peter Clinic
10.8.2 MD Medical Group
10.8.3 IVF Russia (The International Centre of the Reproductive Medicines)

Chapter: 11 REST OF EUROPE EMBRYO TRANSFER MARKET

11.1 Overview
11.2 Rest of Europe IVF Market by Cycle Type

11.2.1 Fresh IVF cycles (non-donor)
11.2.2 Thawed IVF cycles (non-donor)
11.2.3 Donor egg IVF cycles

11.3 Rest of Europe IVF Market by End Users

11.3.1 Fertility clinics
11.3.2 Hospitals
11.3.3 Surgical centers
11.3.4 Clinical research institutes

11.4 Drivers

11.4.1 Wide availability of reimbursements
11.4.2 Emergence of new fertility destinations
11.4.3 Changes in lifestyle

11.5 Restraints
11.6 Regulatory Issues, Legislations, and Authorities
11.7 Insurance Reimbursement Scenario
11.8 Hospitals/Clinics Profiles

11.8.1 Gynaecoloqisch Centrum
11.8.2 Centrum Voor Medische Genetica
11.8.3 Infertility-Vestliitto

List of Figures

FIG. 1 GERMANY IVF MARKET, BY FRESH IVF CYCLES, VOLUME AND VALUE, 2014-2022, (THOUSAND AND $MILLION)
FIG. 2 GERMANY IVF MARKET, BY THAWED IVF CYCLES, VOLUME AND VALUE, 2014-2022, (THOUSAND AND $MILLION)
FIG. 3 GERMANY IVF MARKET, BY FERTILITY CLINICS, VOLUME AND VALUE, 2014-2022, (THOUSAND AND $MILLION)
FIG. 4 GERMANY IVF MARKET, BY HOSPITALS, VOLUME AND VALUE, 2014-2022, (THOUSAND AND $MILLION)
FIG. 5 GERMANY IVF MARKET, BY SURGICAL CENTERS, VOLUME AND VALUE, 2014-2022, (THOUSAND AND $MILLION)
FIG. 6 GERMANY IVF MARKET, BY CLINICAL RESEARCH INSTITUTES, VOLUME AND VALUE, 2014-2022, (THOUSAND AND $MILLION)
FIG. 7 REGULATORY SCENARIO, GERMANY
FIG. 8 FRANCE IVF MARKET, BY FRESH IVF CYCLES, VOLUME AND VALUE, 2014-2022, (THOUSAND AND $MILLION)
FIG. 9 FRANCE IVF MARKET, BY THAWED IVF CYCLES, VOLUME AND VALUE, 2014-2022, (THOUSAND AND $MILLION)
FIG. 10 FRANCE IVF MARKET, BY DONOR EGG IVF CYCLES, VOLUME AND VALUE, 2014-2022, (THOUSAND AND $MILLION)
FIG. 11 FRANCE IVF MARKET, BY FERTILITY CLINICS, VOLUME AND VALUE, 2014-2022, (THOUSAND AND $MILLION)
FIG. 12 FRANCE IVF MARKET, BY HOSPITALS, VOLUME AND VALUE, 2014-2022, (THOUSAND AND $MILLION)
FIG. 13 FRANCE IVF MARKET, BY SURGICAL CENTERS, VOLUME AND VALUE, 2014-2022, (THOUSAND AND $MILLION)
FIG. 14 FRANCE IVF MARKET, BY CLINICAL RESEARCH INSTITUTES, VOLUME AND VALUE, 2014-2022, (THOUSAND AND $MILLION)
FIG. 15 FRANCE: REGULATORY SCENARIO
FIG. 16 UK IVF MARKET, BY FRESH IVF CYCLES, VOLUME AND VALUE, 2014-2022, (THOUSAND AND $MILLION)
FIG. 17 UK IVF MARKET, BY THAWED IVF CYCLES, VOLUME AND VALUE, 2014-2022, (THOUSAND AND $MILLION)
FIG. 18 UK IVF MARKET, BY DONOR EGG IVF CYCLES, VOLUME AND VALUE, 2014-2022, (THOUSAND AND $MILLION)
FIG. 19 UK IVF MARKET, BY FERTILITY CLINICS, VOLUME AND VALUE, 2014-2022, (THOUSAND AND $MILLION)
FIG. 20 UK IVF MARKET, BY HOSPITALS, VOLUME AND VALUE, 2014-2022, (THOUSAND AND $MILLION)
FIG. 21 UK IVF MARKET, BY SURGICAL CENTERS, VOLUME AND VALUE, 2014-2022, (THOUSAND AND $MILLION)
FIG. 22 UK IVF MARKET, BY CLINICAL RESEARCH INSTITUTES, VOLUME AND VALUE, 2014-2022, (THOUSAND AND $MILLION)
FIG. 23 UK: REGULATORY SCENARIO
FIG. 24 ITALY IVF MARKET, BY FRESH IVF CYCLES, VOLUME AND VALUE, 2014-2022, (THOUSAND AND $MILLION)
FIG. 25 ITALY IVF MARKET, BY THAWED IVF CYCLES, VOLUME AND VALUE, 2014-2022, (THOUSAND AND $MILLION)
FIG. 26 ITALY IVF MARKET, BY FERTILITY CLINICS, VOLUME AND VALUE, 2014-2022, (THOUSAND AND $MILLION)
FIG. 27 ITALY IVF MARKET, BY HOSPITALS, VOLUME AND VALUE, 2014-2022, (THOUSAND AND $MILLION)
FIG. 28 ITALY IVF MARKET, BY SURGICAL CENTERS, VOLUME AND VALUE, 2014-2022, (THOUSAND AND $MILLION)
FIG. 29 ITALY IVF MARKET, BY CLINICAL RESEARCH INSTITUTES, VOLUME AND VALUE, 2014-2022, (THOUSAND AND $MILLION)
FIG. 30 SPAIN IVF MARKET, BY FRESH IVF CYCLES, VOLUME AND VALUE, 2014-2022, (THOUSAND AND $MILLION)
FIG. 31 SPAIN IVF MARKET, BY THAWED IVF CYCLES, VOLUME AND VALUE, 2014-2022, (THOUSAND AND $MILLION)
FIG. 32 SPAIN IVF MARKET, BY DONOR EGG IVF CYCLES, VOLUME AND VALUE, 2014-2022, (THOUSAND AND $MILLION)
FIG. 33 SPAIN IVF MARKET, BY FERTILITY CLINICS, VOLUME AND VALUE, 2014-2022, (THOUSAND AND $MILLION)
FIG. 34 SPAIN IVF MARKET, BY HOSPITALS, VOLUME AND VALUE, 2014-2022, (THOUSAND AND $MILLION)
FIG. 35 SPAIN IVF MARKET, BY SURGICAL CENTERS, VOLUME AND VALUE, 2014-2022, (THOUSAND AND $MILLION)
FIG. 36 SPAIN IVF MARKET, BY CLINICAL RESEARCH INSTITUTES, VOLUME AND VALUE, 2014-2022, (THOUSAND AND $MILLION)
FIG. 37 DENMARK IVF MARKET, BY FRESH IVF CYCLES, VOLUME AND VALUE, 2014-2022, (THOUSAND AND $MILLION)
FIG. 38 DENMARK IVF MARKET, BY THAWED IVF CYCLES, VOLUME AND VALUE, 2014-2022, (THOUSAND AND $MILLION)
FIG. 39 DENMARK IVF MARKET, BY DONOR EGG IVF CYCLES, VOLUME AND VALUE, 2014-2022, (THOUSAND AND $MILLION)
FIG. 40 DENMARK IVF MARKET, BY FERTILITY CLINICS, VOLUME AND VALUE, 2014-2022, (THOUSAND AND $MILLION)
FIG. 41 DENMARK IVF MARKET, BY HOSPITALS, VOLUME AND VALUE, 2014-2022, (THOUSAND AND $MILLION)
FIG. 42 DENMARK IVF MARKET, BY SURGICAL CENTERS, VOLUME AND VALUE, 2014-2022, (THOUSAND AND $MILLION)
FIG. 43 DENMARK IVF MARKET, BY CLINICAL RESEARCH INSTITUTES, VOLUME AND VALUE, 2014-2022, (THOUSAND AND $MILLION)
FIG. 44 RUSSIA IVF MARKET, BY FRESH IVF CYCLES, VOLUME AND VALUE, 2014-2022, (THOUSAND AND $MILLION)
FIG. 45 RUSSIA IVF MARKET, BY THAWED IVF CYCLES, VOLUME AND VALUE, 2014-2022, (THOUSAND AND $MILLION)
FIG. 46 RUSSIA IVF MARKET, BY DONOR EGG IVF CYCLES, VOLUME AND VALUE, 2014-2022, (THOUSAND AND $MILLION)
FIG. 47 RUSSIA IVF MARKET, BY FERTILITY CLINICS, VOLUME AND VALUE, 2014-2022, (THOUSAND AND $MILLION)
FIG. 48 RUSSIA IVF MARKET, BY HOSPITALS, VOLUME AND VALUE, 2014-2022, (THOUSAND AND $MILLION)
FIG. 49 RUSSIA IVF MARKET, BY SURGICAL CENTERS, VOLUME AND VALUE, 2014-2022, (THOUSAND AND $MILLION)
FIG. 50 RUSSIA IVF MARKET, BY CLINICAL RESEARCH INSTITUTES, VOLUME AND VALUE, 2014-2022, (THOUSAND AND $MILLION)
FIG. 51 REST OF EUROPE IVF MARKET, BY FRESH IVF CYCLES, VOLUME AND VALUE, 2014-2022, (THOUSAND AND $MILLION)
FIG. 52 REST OF EUROPE IVF MARKET, BY THAWED IVF CYCLES, VOLUME AND VALUE, 2014-2022, (THOUSAND AND $MILLION)
FIG. 53 REST OF EUROPE IVF MARKET, BY DONOR EGG IVF CYCLES, VOLUME AND VALUE, 2014-2022, (THOUSAND AND $MILLION)
FIG. 54 REST OF EUROPE IVF MARKET, BY FERTILITY CLINICS, VOLUME AND VALUE, 2014-2022, (THOUSAND AND $MILLION)
FIG. 55 REST OF EUROPE IVF MARKET, BY HOSPITALS, VOLUME AND VALUE, 2014-2022, (THOUSAND AND $MILLION)
FIG. 56 REST OF EUROPE IVF MARKET, BY SURGICAL CENTERS, VOLUME AND VALUE, 2014-2022, (THOUSAND AND $MILLION)
FIG. 57 REST OF EUROPE IVF MARKET, BY CLINICAL RESEARCH INSTITUTES, VOLUME AND VALUE, 2014-2022, (THOUSAND AND $MILLION)

List of Tables

TABLE 1 IVF SUCCESS RATES ACCORDING TO AGE
TABLE 2 EUROPE, IVF MARKET, 2014-2022 (THOUSAND)
TABLE 3 EUROPE, IVF MARKET, 2014-2022 ($MILLION)
TABLE 4 EUROPE IVF MARKET, BY CYCLE TYPE, 2014-2022, (THOUSAND)
TABLE 5 EUROPE IVF MARKET, BY CYCLE TYPE, 2014-2022, ($MILLION)
TABLE 6 EUROPE IVF MARKET, BY END USERS, 2014-2022 (THOUSAND)
TABLE 7 EUROPE IVF MARKET, BY END USERS, 2014-2022 ($MILLION)
TABLE 8 THERMO FISHER SCIENTIFIC, INC. BUSINESS OVERVIEW
TABLE 9 COMPANY SNAPSHOT
TABLE 10 DRK KLINIKEN BERLIN OVERVIEW
TABLE 11 SNAPSHOT OF DRK KLINIKEN BERLIN
TABLE 12 SUN PHARMACEUTICAL BUSINESS OVERVIEW
TABLE 13 COMPANY SNAPSHOT
TABLE 14 CADILA HEALTH CARE BUSINESS OVERVIEW
TABLE 15 COMPANY SNAPSHOT
TABLE 16 LG LIFE SCIENCE BUSINESS OVERVIEW
TABLE 17 COMPANY SNAPSHOT
TABLE 18 GERMANY IVF MARKET, VOLUME AND VALUE, 2014-2022 (THOUSAND AND $MILLION)
TABLE 19 GERMANY IVF MARKET, BY CYCLE TYPE, 2014-2022 ($MILLION)
TABLE 20 GERMANY IVF MARKET, BY CYCLE TYPE, 2014-2022 (THOUSAND)
TABLE 21 GERMANY IVF MARKET, BY END USERS, 2014-2022 (THOUSAND)
TABLE 22 GERMANY IVF MARKET, BY END USERS, 2014-2022 ($MILLION)
TABLE 23 HEIDELBERG UNIVERSITY HOSPITAL OVERVIEW
TABLE 24 SNAPSHOT OF HEIDELBERG UNIVERSITY HOSPITAL
TABLE 25 KLINIKUM STUTTGART OVERVIEW
TABLE 26 COMPANY SNAPSHOT
TABLE 27 DRK KLINIKEN BERLIN OVERVIEW
TABLE 28 SNAPSHOT OF DRK KLINIKEN BERLIN
TABLE 29 UNIVERSITY MEDICAL CENTER FREIBURG OVERVIEW
TABLE 30 SNAPSHOT OF UNIVERSITY MEDICAL CENTER FREIBURG
TABLE 31 FRANCE IVF MARKET, VOLUME AND VALUE, 2014-2022 (THOUSAND AND $MILLION)
TABLE 32 FRANCE IVF MARKET, BY CYCLE TYPE, 2014-2022 ($MILLION)
TABLE 33 FRANCE IVF MARKET, BY CYCLE TYPE, 2014-2022 (THOUSAND)
TABLE 34 FRANCE IVF MARKET, BY END USERS, 2014-2022 (THOUSAND)
TABLE 35 FRANCE IVF MARKET, BY END USERS, 2014-2022 ($MILLION)
TABLE 36 CLINIQUE DE LA MUETTE OVERVIEW
TABLE 37 SNAPSHOT OF CLINIQUE DE LA MUETTE
TABLE 38 HOPITAL DES METALLURGISTS, HOPITAL COCHIN OVERVIEW
TABLE 39 SNAPSHOT OF HOPITAL DES METALLURGISTS, HOPITAL COCHIN
TABLE 40 UK: IVF CYCLES BY VARIOUS AGE GROUPS, 2011
TABLE 41 UK: PROPORTION OF IVF CYCLES USING FRESH AND FROZEN EGGS, 2010-2011
TABLE 42 UK: IVF SUCCESS RATES (AS PER NHS), 2010
TABLE 43 UK: REGIONAL IVF CLINICS AND TOTAL NUMBER OF WOMEN TREATED, 2011
TABLE 44 UK IVF MARKET, VOLUME AND VALUE, 2014-2022 (THOUSAND AND $MILLION)
TABLE 45 UK IVF MARKET, BY CYCLE TYPE, 2014-2022 ($MILLION)
TABLE 46 UK IVF MARKET BY CYCLE TYPE, 2014-2022 (THOUSAND)
TABLE 47 UK IVF MARKET, BY END USERS, 2014-2022 (THOUSAND)
TABLE 48 UK IVF MARKET, BY END USERS, 2014-2022 ($MILLION)
TABLE 49 LISTER FERTILITY CLINIC OVERVIEW
TABLE 50 COMPANY SNAPSHOT
TABLE 51 THE BRIDGE CENTER OVERVIEW
TABLE 52 SNAPSHOT OF THE BRIDGE CENTER
TABLE 53 CHELSEA AND WESTMINSTER HOSPITAL OVERVIEW
TABLE 54 SNAPSHOT OF CHELSEA AND WESTMINSTER HOSPITAL
TABLE 55 ITALY IVF MARKET, VOLUME AND VALUE, 2014-2022 (THOUSAND AND $MILLION)
TABLE 56 ITALY IVF MARKE, BY CYCLE TYPE, 2014-2022 ($MILLION)
TABLE 57 ITALY IVF MARKET, BY CYCLE TYPE, 2014-2022 (THOUSAND)
TABLE 58 ITALY IVF MARKET, BY END USERS, 2014-2022 ($MILLION)
TABLE 59 ITALY IVF MARKET, BY END USERS, 2014-2022 (THOUSAND)
TABLE 60 SPAIN IVF MARKET, VOLUME AND VALUE, 2014-2022 (THOUSAND AND $MILLION)
TABLE 61 SPAIN IVF MARKET, BY CYCLE TYPE, 2014-2022 ($MILLION)
TABLE 62 SPAIN IVF MARKET, BY CYCLE TYPE, 2014-2022 (THOUSAND)
TABLE 63 SPAIN IVF MARKET, BY END USERS, 2014-2022 ($MILLION)
TABLE 64 SPAIN IVF MARKET, BY END USERS, 2014-2022 (THOUSAND)
TABLE 65 DENMARK IVF MARKET, VOLUME AND VALUE, 2014-2022 (THOUSAND AND $MILLION)
TABLE 66 DENMARK IVF MARKET, BY CYCLE TYPE, 2014-2022 ($MILLION)
TABLE 67 DENMARK IVF MARKET, BY CYCLE TYPE, 2014-2022 (THOUSAND)
TABLE 68 DENMARK IVF MARKET, BY END USERS, 2014-2022 ($MILLION)
TABLE 69 DENMARK IVF MARKET, BY END USERS, 2014-2022 (THOUSAND)
TABLE 70 RUSSIA IVF MARKET, VOLUME AND VALUE, 2014-2022 (THOUSAND AND $MILLION)
TABLE 71 RUSSIA IVF MARKET, BY CYCLE TYPE, 2014-2022 ($MILLION)
TABLE 72 RUSSIA IVF MARKET, BY CYCLE TYPE, 2014-2022 (THOUSAND)
TABLE 73 RUSSIA IVF MARKET, BY END USERS, 2014-2022 ($MILLION)
TABLE 74 RUSSIA IVF MARKET, BY END USERS, 2014-2022 (THOUSAND)
TABLE 75 REST OF EUROPE IVF MARKET, VOLUME AND VALUE, 2014-2022 (THOUSNAD AND $MILLION)
TABLE 76 REST OF EUROPE IVF MARKET, BY CYCLE TYPE, 2014-2022 ($MILLION)
TABLE 77 REST OF EUROPE IVF MARKET, BY CYCLE TYPE, 2014-2022 (THOUSAND)
TABLE 78 REST OF EUROPE IVF MARKET, BY END USERS, 2014-2022 ($MILLION)
TABLE 79 REST OF EUROPE IVF MARKET, BY END USERS, 2014-2022 (THOUSAND)